676
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

HDAC inhibitor sodium butyrate sensitizes E1A+Ras-transformed cells to DNA damaging agents by facilitating formation and persistence of γH2AX foci

, , , , &
Pages 1069-1077 | Received 19 Aug 2011, Accepted 11 Oct 2011, Published online: 15 Dec 2011

References

  • Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389:349 - 52; http://dx.doi.org/10.1038/38664; PMID: 9311776
  • Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 1999; 9:40 - 8; http://dx.doi.org/10.1016/S0959-437X(99)80006-9; PMID: 10072350
  • Villar-Garea A, Esteller M. Histone deacetylase inhibitors: Understanding a new wave of anticancer agents. Int J Cancer 2004; 112:171 - 8; http://dx.doi.org/10.1002/ijc.20372; PMID: 15352027
  • Wade PA, Wolffe AP. Histone acetyltransferases in control. Curr Biol 1997; 7:R82 - 4; http://dx.doi.org/10.1016/S0960-9822(06)00042-X; PMID: 9081669
  • Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996; 5:245 - 53; PMID: 8723390
  • Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92:1210 - 6; http://dx.doi.org/10.1093/jnci/92.15.1210; PMID: 10922406
  • Johnstone RW. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1:287 - 99; http://dx.doi.org/10.1038/nrd772; PMID: 12120280
  • Koprinarova M, Botev P, Russev G. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination. DNA Repair (Amst) 2011; 10:970 - 7; http://dx.doi.org/10.1016/j.dnarep.2011.07.003; PMID: 21824827
  • Karagiannis TC, El-Osta A. Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 2006; 25:3885 - 93; http://dx.doi.org/10.1038/sj.onc.1209417; PMID: 16462761
  • Lindemann RK, Gabrielli B, Johnstone RW. Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle 2004; 3:779 - 88; http://dx.doi.org/10.4161/cc.3.6.927; PMID: 15153801
  • Zhang Y, Adachi M, Zou H, Hareyama M, Imai K, Shinomura Y. Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation. Int J Radiat Oncol Biol Phys 2006; 65:859 - 66; http://dx.doi.org/10.1016/j.ijrobp.2006.03.019; PMID: 16751067
  • Abramova MV, Pospelova TV, Nikulenkov FP, Hollander CM, Fornace AJ Jr., Pospelov VA. G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A+Ras-transformed cells is mediated through downregulation of E2F activity and stabilization of beta-catenin. J Biol Chem 2006; 2:21040 - 51; http://dx.doi.org/10.1074/jbc.M511059200
  • Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:1 - 7; http://dx.doi.org/10.4161/cc.8.24.10215; PMID: 19182532
  • Tanaka T, Halicka D, Traganos F, Darzynkiewicz Z. Cytometric analysis of DNA damage: phosphorylation of histone H2AX as a marker of DNA double-strand breaks (DSBs). Methods Mol Biol 2009; 523:161 - 8; http://dx.doi.org/10.1007/978-1-59745-190-1_11; PMID: 19381940
  • Olive PL, Banath JP. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 2006; 1:23 - 9; http://dx.doi.org/10.1038/nprot.2006.5; PMID: 17406208
  • Pehrson JR, Fuji RN. Evolutionary conservation of histone macroH2A subtypes and domains. Nucleic Acids Res 1998; 26:2837 - 42; http://dx.doi.org/10.1093/nar/26.12.2837; PMID: 9611225
  • Riches LC, Lynch A, Gooderham NJ. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 2008; 23:331 - 9; http://dx.doi.org/10.1093/mutage/gen039; PMID: 18644834
  • Park E-J, Chan DW, Park J-H, Oettinger MA, Kwon J. DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner. Nucleic Acids Res 2003; 31:6819 - 27; http://dx.doi.org/10.1093/nar/gkg921; PMID: 14627815
  • Chuykin IA, Lianguzova MS, Pospelova TV, Pospelov VA. Activation of DNA damage response signaling in mouse embryonic stem cells. Cell Cycle 2008; 7:2922 - 8; http://dx.doi.org/10.4161/cc.7.18.6699; PMID: 18787397
  • Soutoglou E, Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 2008; 320:1507 - 10; http://dx.doi.org/10.1126/science.1159051; PMID: 18483401
  • Hunt CR, Pandita RK, Laszlo A, Higashikubo R, Agarwal M, Kitamura T, et al. Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res 2007; 67:3010 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-06-4328; PMID: 17409407
  • Laszlo A, Fleischer I. The heat-induced gamma-H2AX response does not play a role in hyperthermic cell killing. Int J Hyperthermia 2009; 25:199 - 209; http://dx.doi.org/10.1080/02656730802631775; PMID: 19437236
  • Abramova MV, Zatulovskiy EA, Svetlikova SB, Pospelov VA. HDAC inhibitor-induced activation of NF-κB prevents apoptotic response of E1A+Ras-transformed cells to proapoptotic stimuli. Int J Biochem Cell Biol 2010; 42:1847 - 55; http://dx.doi.org/10.1016/j.biocel.2010.08.001; PMID: 20692358
  • Romanov VS, Abramova MV, Svetlikova SB, Bykova TV, Zubova SG, Aksenov ND, et al. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate. Cell Cycle 2010; 9:3945 - 55; http://dx.doi.org/10.4161/cc.9.19.13160; PMID: 20935470
  • Misteli T, Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 2009; 10:243 - 54; http://dx.doi.org/10.1038/nrm2651; PMID: 19277046
  • Ichijima Y, Sakasai R, Okita N, Asahina K, Mizutani S, Teraoka H. Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. Biochem Biophys Res Commun 2005; 336:807 - 12; http://dx.doi.org/10.1016/j.bbrc.2005.08.164; PMID: 16153602
  • McManus KJ, Hendzel MJ. ATM-dependent and DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol Biol Cell 2005; 16:5013 - 25; http://dx.doi.org/10.1091/mbc.E05-01-0065; PMID: 16030261
  • Ziegler-Birling C, Helmrich A, Tora L, Torres-Padilla ME. Distribution of p53 binding protein 1 (53BP1) and phosphorylated H2A.X during mouse preimplantation development in the absence of DNA damage. Int J Dev Biol 2009; 53:1003 - 11; http://dx.doi.org/10.1387/ijdb.082707cz; PMID: 19598117
  • Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, et al. Enhanced radiation-induced cell killing and prolongation of γH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 2004; 64:316 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-03-2630; PMID: 14729640
  • Chinnaiyan P, Cerna D, Burgan WE, Beam K, Williams ES, Camphausen K, et al. Postradiation sensitization of the histone deacetylase inhibitor valproic acid. Clin Cancer Res 2008; 14:5410 - 5; http://dx.doi.org/10.1158/1078-0432.CCR-08-0643; PMID: 18765532
  • Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 2003; 63:7291 - 300; PMID: 14612526
  • Kim M-K, Shin J-M, Eun HC, Chung JH. The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription. PLoS ONE 2009; 4:e4864; http://dx.doi.org/10.1371/journal.pone.0004864; PMID: 19287485
  • Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13:292 - 302; http://dx.doi.org/10.1038/ncb2170; PMID: 21336312
  • Lee OP, Choy ML, Ngo L, Foster SS, Marks PA. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA 2010; 107:14639 - 44; http://dx.doi.org/10.1073/pnas.1008522107; PMID: 20679231
  • Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 2005; 11:4912 - 22; http://dx.doi.org/10.1158/1078-0432.CCR-04-2088; PMID: 16000590
  • Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM, Meyn RE. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther 2006; 5:1967 - 74; http://dx.doi.org/10.1158/1535-7163.MCT-06-0022; PMID: 16928817
  • Chen CS, Wang YC, Yang HC, Huang PH, Kulp SK, Yang CC, et al. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. Cancer Res 2007; 67:5318 - 27; http://dx.doi.org/10.1158/0008-5472.CAN-06-3996; PMID: 17545612
  • Kachhap SK, Rosmus N, Collis SJ, Kortenhorst M, Wissing MD, Hedayati M, et al. Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor. PLoS ONE 2010; 5:e11208; http://dx.doi.org/10.1371/journal.pone.0011208; PMID: 20585447
  • Kim GD, Choi YH, Dimtchev A, Jeong SJ, Dritschilo A, Jung M. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J Biol Chem 1999; 274:31127 - 30; http://dx.doi.org/10.1074/jbc.274.44.31127; PMID: 10531300
  • Schmidt DR, Schreiber SL. Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry 1999; 38:14711 - 7; http://dx.doi.org/10.1021/bi991614n; PMID: 10545197
  • Johnson CA, Padget K, Austin CA, Turner BM. Deacetylase Activity Associates with Topoisomerase II and Is Necessary for Etoposide-induced Apoptosis. J Biol Chem 2001; 276:4539 - 42; http://dx.doi.org/10.1074/jbc.C000824200; PMID: 11136718
  • Peng A, Maller JL. Serine/threonine phosphatases in the DNA damage response and cancer. Oncogene 2010; 29:5977 - 88; http://dx.doi.org/10.1038/onc.2010.371; PMID: 20838380
  • Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S. Deacetylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J Biol Chem 2004; 279:7685 - 91; http://dx.doi.org/10.1074/jbc.M310997200; PMID: 14670976
  • Canettieri G, Morantte I, Guzm´n E, Asahara H, Herzig S, Anderson SD, et al. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat Struct Biol 2003; 10:175 - 81; http://dx.doi.org/10.1038/nsb895; PMID: 12567184
  • Cha H, Lowe JM, Li H, Lee J, Belova G, Bulavin D, et al. Wip1 Directly Dephosphorylates γ-H2AX and Attenuates the DNA Damage Response. Cancer Res 2010; 70:1213 - 23; http://dx.doi.org/10.1158/0008-5472.CAN-09-4244

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.